SCHEMBL6602979

SCHEMBL6602979

CCCC[Sn](CCCC)(CCCC)c1cnn(COC(C)[Si](C)(C)C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2354097 0.77 KMT2A (0.34)
SCHEMBL6603663 0.71 HPGD (0.38)
SCHEMBL1427291 0.71 ACHE (0.35)
SCHEMBL2356296 0.69 ALDH1A1 (0.33)
SCHEMBL28394743 0.67 ACHE (0.35)
SCHEMBL29219229 0.65
SCHEMBL508861 0.63 NPC1 (0.44)
SCHEMBL7244739 0.62 GAA (0.44)
SCHEMBL21877327 0.60 MTOR (0.32)
SCHEMBL561256 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1072601-B1 4-arylpiperidine derivatives for the treatment of pruritus PFIZER (US) 2004-09-08 EP disclosed
US-6750231-B2 SKIN DISORDERS; GASTROINTESTINAL DISORDERS PFIZER INC 2004-06-15 US disclosed
US-20030004340-A1 New 4-arylpiperidine derivatives for the treatment of pruritus GIBSON STEPHEN PAUL (GB) 2003-01-02 US disclosed
EP-1072601-A2 4-arylpiperidine derivatives for the treatment of pruritus PFIZER INC. (US) 2001-01-31 EP disclosed